A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy

Transcatheter arterial chemoembolization (TACE) has become the preferred therapy for unresectable advanced hepatocellular carcinoma (HCC). However, the embolization of tumor-feeding arteries by TACE always leads to hypoxia-related tumor angiogenesis, which limited the therapeutic effect for HCC. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dongyuan, Liu, Jiacheng, Li, Tongqiang, Wang, Yingliang, Liu, Xiaoming, Bai, Yaowei, Wang, Chaoyang, Ju, Shuguang, Huang, Songjiang, Yang, Chongtu, Zhou, Chen, Zhang, Yu, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537177/
https://www.ncbi.nlm.nih.gov/pubmed/36202781
http://dx.doi.org/10.1038/s41420-022-01198-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537177/
https://www.ncbi.nlm.nih.gov/pubmed/36202781
http://dx.doi.org/10.1038/s41420-022-01198-9

Ejemplares similares